TRICIDA INC's ticker is TCDA and the CUSIP is 89610F101. A total of 77 filers reported holding TRICIDA INC in Q3 2021. The put-call ratio across all filers is 0.27 and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q4 2022 | $1,000 | -97.7% | 3,767 | -8.9% | 0.00% | – |
| Q3 2022 | $43,000 | +514.3% | 4,135 | +501.9% | 0.00% | – |
| Q2 2022 | $7,000 | -87.3% | 687 | -89.8% | 0.00% | – |
| Q1 2022 | $55,000 | +103.7% | 6,747 | +8.8% | 0.00% | – |
| Q2 2021 | $27,000 | -73.0% | 6,202 | -67.0% | 0.00% | – |
| Q1 2021 | $100,000 | -21.3% | 18,809 | +4.2% | 0.00% | – |
| Q4 2020 | $127,000 | -27.0% | 18,043 | -6.1% | 0.00% | – |
| Q3 2020 | $174,000 | -53.4% | 19,225 | +41.8% | 0.00% | – |
| Q2 2020 | $373,000 | +24.3% | 13,557 | -0.6% | 0.00% | – |
| Q1 2020 | $300,000 | -47.5% | 13,632 | -10.0% | 0.00% | – |
| Q4 2019 | $571,000 | +31.0% | 15,149 | +7.2% | 0.00% | – |
| Q3 2019 | $436,000 | +101.9% | 14,125 | +158.0% | 0.00% | – |
| Q2 2019 | $216,000 | +369.6% | 5,475 | +356.2% | 0.00% | – |
| Q1 2019 | $46,000 | +283.3% | 1,200 | +140.0% | 0.00% | – |
| Q4 2018 | $12,000 | -53.8% | 500 | -40.9% | 0.00% | – |
| Q3 2018 | $26,000 | +766.7% | 846 | +746.0% | 0.00% | – |
| Q2 2018 | $3,000 | – | 100 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Orbimed Advisors | 9,614,280 | $362,843,000 | 5.18% |
| Redmile Group, LLC | 2,129,100 | $80,352,000 | 1.92% |
| Burrage Capital Management LLC | 70,653 | $2,666,000 | 1.79% |
| Avoro Capital Advisors LLC | 1,560,000 | $58,874,000 | 1.73% |
| Opaleye Management Inc. | 194,000 | $7,303,000 | 1.43% |
| Cormorant Asset Management, LP | 927,975 | $35,022,000 | 1.40% |
| Duquesne Family Office | 688,344 | $25,978,000 | 0.76% |
| H2O AM LLP | 67,991 | $2,566,000 | 0.61% |
| Artal Group S.A. | 360,000 | $13,586,000 | 0.52% |
| INTERNATIONAL BIOTECHNOLOGY TRUST PLC | 37,000 | $1,393,000 | 0.50% |